Correlation Between GeneReach Biotechnology and TWOWAY Communications
Can any of the company-specific risk be diversified away by investing in both GeneReach Biotechnology and TWOWAY Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneReach Biotechnology and TWOWAY Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeneReach Biotechnology and TWOWAY Communications, you can compare the effects of market volatilities on GeneReach Biotechnology and TWOWAY Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneReach Biotechnology with a short position of TWOWAY Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneReach Biotechnology and TWOWAY Communications.
Diversification Opportunities for GeneReach Biotechnology and TWOWAY Communications
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between GeneReach and TWOWAY is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and TWOWAY Communications in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TWOWAY Communications and GeneReach Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneReach Biotechnology are associated (or correlated) with TWOWAY Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TWOWAY Communications has no effect on the direction of GeneReach Biotechnology i.e., GeneReach Biotechnology and TWOWAY Communications go up and down completely randomly.
Pair Corralation between GeneReach Biotechnology and TWOWAY Communications
Assuming the 90 days trading horizon GeneReach Biotechnology is expected to under-perform the TWOWAY Communications. But the stock apears to be less risky and, when comparing its historical volatility, GeneReach Biotechnology is 2.64 times less risky than TWOWAY Communications. The stock trades about -0.02 of its potential returns per unit of risk. The TWOWAY Communications is currently generating about 0.33 of returns per unit of risk over similar time horizon. If you would invest 9,510 in TWOWAY Communications on November 5, 2024 and sell it today you would earn a total of 2,190 from holding TWOWAY Communications or generate 23.03% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GeneReach Biotechnology vs. TWOWAY Communications
Performance |
| Timeline |
| GeneReach Biotechnology |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| TWOWAY Communications |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Modest
GeneReach Biotechnology and TWOWAY Communications Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GeneReach Biotechnology and TWOWAY Communications
The main advantage of trading using opposite GeneReach Biotechnology and TWOWAY Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneReach Biotechnology position performs unexpectedly, TWOWAY Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TWOWAY Communications will offset losses from the drop in TWOWAY Communications' long position.The idea behind GeneReach Biotechnology and TWOWAY Communications pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |